share_log

Retail Investors Among Lotus Health Group Company's (SHSE:600186) Largest Stockholders and Were Hit After Last Week's 10.0% Price Drop

Retail Investors Among Lotus Health Group Company's (SHSE:600186) Largest Stockholders and Were Hit After Last Week's 10.0% Price Drop

散戶投資者是蓮花健康集團公司(SHSE: 600186)的最大股東,在上週價格下跌10.0%後受到打擊
Simply Wall St ·  01/26 17:22

Key Insights

關鍵見解

  • Significant control over Lotus Health Group by retail investors implies that the general public has more power to influence management and governance-related decisions
  • A total of 14 investors have a majority stake in the company with 47% ownership
  • Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
  • 散戶投資者對蓮花健康集團的嚴格控制意味着公衆擁有更大的影響管理和治理相關決策的權力
  • 共有14名投資者持有該公司的多數股權,所有權爲47%
  • 使用公司過去業績的數據以及所有權研究,可以更好地評估公司的未來表現

Every investor in Lotus Health Group Company (SHSE:600186) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 53% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

蓮花健康集團公司(SHSE: 600186)的每位投資者都應該知道最強大的股東群體。我們可以看到,散戶投資者擁有該公司的大部分股份,所有權爲53%。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

And following last week's 10.0% decline in share price, retail investors suffered the most losses.

繼上週股價下跌10.0%之後,散戶投資者遭受的損失最大。

Let's take a closer look to see what the different types of shareholders can tell us about Lotus Health Group.

讓我們仔細看看不同類型的股東能告訴我們有關蓮花健康集團的哪些信息。

View our latest analysis for Lotus Health Group

查看我們對蓮花健康集團的最新分析

ownership-breakdown
SHSE:600186 Ownership Breakdown January 26th 2024
SHSE: 600186 所有權明細 2024 年 1 月 26 日

What Does The Institutional Ownership Tell Us About Lotus Health Group?

關於蓮花健康集團,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

We can see that Lotus Health Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Lotus Health Group's historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到,蓮花健康集團確實有機構投資者;他們持有該公司很大一部分股票。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。當多家機構擁有一隻股票時,總是存在處於 “擁擠交易” 的風險。當這樣的交易出錯時,多方可能會競相快速出售股票。對於沒有增長曆史的公司,這種風險更高。你可以在下面看到蓮花健康集團的歷史收益和收入,但請記住,故事總是有更多內容。

earnings-and-revenue-growth
SHSE:600186 Earnings and Revenue Growth January 26th 2024
SHSE: 600186 收益和收入增長 2024 年 1 月 26 日

We note that hedge funds don't have a meaningful investment in Lotus Health Group. Zhoukou Chengtou Development Group Co., Ltd. is currently the company's largest shareholder with 13% of shares outstanding. For context, the second largest shareholder holds about 10% of the shares outstanding, followed by an ownership of 5.0% by the third-largest shareholder.

我們注意到,對沖基金沒有對蓮花健康集團進行有意義的投資。周口城投發展集團有限公司目前是該公司的最大股東,已發行股份的13%。就背景而言,第二大股東持有約10%的已發行股份,其次是第三大股東持有5.0%的所有權。

Our studies suggest that the top 14 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我們的研究表明,前14名股東共同控制的公司股份不到一半,這意味着公司的股票分佈廣泛,沒有占主導地位的股東。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

研究機構所有權是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以達到同樣的目的。據我們所知,沒有分析師對該公司進行報道,因此它可能處於雷達之下。

Insider Ownership Of Lotus Health Group

蓮花健康集團的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。公司管理層經營業務,但首席執行官將對董事會負責,即使他或她是董事會成員。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

We note our data does not show any board members holding shares, personally. Not all jurisdictions have the same rules around disclosing insider ownership, and it is possible we have missed something, here. So you can click here learn more about the CEO.

我們注意到,我們的數據並未顯示任何董事會成員個人持有股份。並非所有司法管轄區在披露內部所有權方面都有相同的規則,我們有可能在這裏遺漏了一些東西。因此,您可以單擊此處了解有關首席執行官的更多信息。

General Public Ownership

一般公有制

The general public -- including retail investors -- own 53% of Lotus Health Group. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

包括散戶投資者在內的公衆擁有蓮花健康集團53%的股份。這種所有權規模賦予了公衆投資者一定的集體權力。他們可以而且可能確實會影響有關高管薪酬、股息政策和擬議業務收購的決策。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 38%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們的數據表明,私人公司持有公司38%的股份。可能值得對此進行更深入的研究。如果關聯方,例如內部人士,對其中一傢俬營公司有興趣,則應在年度報告中披露。私營公司也可能在公司中擁有戰略利益。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 2 warning signs we've spotted with Lotus Health Group (including 1 which is potentially serious) .

我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。爲此,你應該了解我們在 Lotus Health Group 發現的 2 個警告信號(包括 1 個可能嚴重的警告信號)。

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最值得買入的股票。因此,來看看這份免費的有趣公司名單吧。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論